63
Views
26
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

Acinetobacter baumannii: Emergence of Four Strains with Novel blaOXA-51-like Genes in Patients with Diabetes Mellitus

Pages 290-295 | Published online: 18 Jul 2013

REFERENCES

  • International Diabetes Federation (IDF). Did you know? Facts and figures. Diabetes Atlas 2007; diabetes unit: 3rd edition.
  • Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, and Carmeli Y. Multi-drug-resistant Acineto-bacter baumannii. Emerg Infect Dis 2005; 11: 22–9.
  • Villers D, Espaze E, Coste-Burel M, Giauffret F, Ninin E, Nicolas F, et al. Nosocomial Acinetobacter baumannii infections: Microbiological and Clinical Epidemiology. Ann Intern Med 1998; 129: 182–9.
  • Wagenvoort J H, De Brauwer E I, Toenbreker H M, van der Linden C J. An outbreak Acinetobacter baumannii that mimics MRSA in its environmental longevity. J Hosp Infect 2002; 52: 226–7.
  • Rello J, Diaz E. Acinetobacter baumannii a threat for the ICU. Intensive Care Med 2003; 29: 350–1.
  • Garcia-Garmendia J L, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez F J, Perez-Paredes C, Barrero-Almodovar A E, et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis 2001; 33: 939–46.
  • Furniss D, Gore S, Azadian B, Myers S R. Acinetobacter infection is associated with acquired glucose intolerance in burn patients. J Burn Care Rehabil 2005; 26: 405–8.
  • Joly-Guillou, M. L. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005; 11: 868–73.
  • Falagas M E, Karveli E A, Kelesidis I, Kelesidis T. community-acquired Acinetobacter infections. Eur J Clin Microbiol In-fect Dis 2007; 26: 857–68.
  • Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acineto-bacter baumannii. Antimicrob Agents Chemother 2007; 51: 3471–84.
  • Valtenet D, Nordmann P, Barbe V, Poiret L, Mangenot S, Bataille E, et al. Comparative Analysis of Acinetobacters: Three Genomes for Three Lifestyles. PLoS ONE 2008;(3).
  • Livermore D M, Woodford N. Carbapenemases: a prob-lem in waiting. Curr Opin Microbiol 2000; 3: 489–95.
  • Guerin F, Henegar C, Spiridon G, Launay O, Salmon-Ceron D, Poyart C. Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaw,„ metallo[beta]-lactamase gene from Saudi Arabia. J Antimicrob Chemother 2005; 56: 601.
  • Al-Tawfiq J A & Mohandhas T X. Prevalence of antimi-crobial resistance in Acinetobacter calcoaceticus-baumannii complex in a Saudi Arabian hospital. Infect Control Hosp Epi-demiol 2007; 28: 870-2.
  • Babay HA, Kambal AM, Al-Anazy, AR, Saidu AB, Aziz S. Acinetobacter blood stream infection in a teaching hospital-Riyadh, Saudi Arabia. Kuwait Med J 2003; 35: 196–201.
  • Babay H A H. Antimicrobial Resistance among Clinical Isolates of Pseudomonas aeruginosa from Patients in a Teach-ing Hospital, Riyadh, Saudi Arabia, 2001-2005. Jpn. J. Infect. Dis 2007; 60: 123–125.
  • Habib Babay H A. Ciprofloxacin resistance among bacte-rial isolates in a teaching hospital in Riyadh Saudi Arabia 2001-2005. Pak J Med Sci 2007; 23: 39–42.
  • AL-Jaser AM. Extended-spectrum Beta-lactamases (ESBL): A global problem. Kuwait Med J 2006; 3: 171-185.
  • Woodford N, Ellington M J, Coelho J M, Turton J F, Ward M E, Brown S, et al. Multiplex PCR for genes encoding preva-lent OXA carbapenemases in Acinetobacter spp. Int J Antimi-crob Agents 2006; 27: 351–3.
  • Turton JF, Woodford N, Glover J, Yarde S, Kaufmann M E, Pitt TL. Identification of Acinetobacter baumannii by detec-tion of the blaom_like carbapenemase gene intrinsic to this species. J Clin Microbiol, 2006; 44: 2974–6.
  • Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAbal in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Mi-crobiol Lett 2006; 258: 72–77.
  • Dolzani L, Tonin E, Lagatolla C, Prandin L, Monti-Bra-gadin C. Identification of Acinetobacter isolates in the A. cal-coaceticus-A. baumannii complex by restriction analysis of the 16S-23S rRNA intergenic-spacer sequences. J Clin Microbiol 1995; 33: 1108–13.
  • Heritier C, Poiret L, Fournier PE, Claverie JM, Raoul D, Nordmann P. Characterization of the naturally occurring oxacil-linase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 59: 5174–4179.
  • Heritier C, Poiret L, Nordmann P. Cephalosporinase over-expression resulting from insertion of ISAbal in Acinetobacter baumannii. Clin Microbiol Infect 2006; 12: 123–30.
  • Miranda G, Kelly C, Solorzano F, Leanos B, Coria R, Patterson J E. Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neona-tal intensive care unit. J Clin Microbiol 1996; 34: 3138–3141.
  • Andrews J M. Determination of minimum inhibitory con-centrations. J Antimicrob Chemother 2001; 48: 5–16.
  • Poirel L, Nordmann P. Carbapenem resistance in Acine-tobacter baumannii: mechanisms and epidemiology. Clin Mi-crobiol Infect 2006; 12: 826–36.
  • Manjinder S, Sandhu E, Inês Barroso. The usual suspects: a new gene affecting diabetes. J Nature Genetics, 2007; 2nd July: http://www.cienciahoie.pt/index.php?oid=22542&op=all.
  • Brown S, Young H K, Amyes S G. Characterisation of OXA-51, a novel class D carbapenemase found in genetically un-related clinical strains of Acinetobacter baumannii from Ar-gentina. Clin Microbiol Infect 2005; 11: 15–23.
  • Livermore D M, Woodford N. The 13-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 2006; 14: 413–420.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.